Article: Management of factor XI deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange: A case report.
2021 Volume 60, Issue 5, Page(s) 103176
Abstract: Introduction: Factor XI (FXI) deficiency is a rare congenital hemostatic disorder associated with increased bleeding tendency in trauma, surgery or when other hemostatic defects are present. Perioperative hemostatic management of a patient with a severe ...
Abstract | Introduction: Factor XI (FXI) deficiency is a rare congenital hemostatic disorder associated with increased bleeding tendency in trauma, surgery or when other hemostatic defects are present. Perioperative hemostatic management of a patient with a severe FXI deficiency undergoing major oncological liver and colorectal surgery with therapeutic plasma exchange (TPE) with fresh frozen plasma (FFP) is reported. Case description: A 54-year-old male with severe FXI deficiency was scheduled for resection of synchronous rectal cancer and multiple liver metastases. Baseline prothrombin time (PT) was 97 %, activated partial thromboplastin time (aPTT) 89 s(s) and FXI levels <1 IU/dL. The rotational thromboelastometry (ROTEM™) presented a prolonged INTEM clotting time (CT) = 443 s (RV 100-240 s) and a clot formation time (CFT) = 110 s (RV 30-100 s). TPE with FFP was carried out achieving FXI levels up to 46 IU/dL and an aPTT of 33 s, normalizing thromboelastometry parameters to an INTEM CT = 152 s and a CFT = 86 s before the procedure. After surgery, the patient received daily FFP to maintain FXI levels above 30 IU/dL until discharge on the eighth day. A total of 30 FFP units were transfused during hospital stay. No significant bleeding events neither transfusion related complications were observed during the perioperative period. Conclusion: Given the lack of correlation between FXI levels and bleeding risk, a multidisciplinary approach based on daily FXI levels monitoring, close clinical assessment and factor supplementation is mandatory. In conclusion, TPE with FFP is an efficacious alternative strategy to correct severe FXI deficiency in patients undergoing major surgery. |
---|---|
MeSH term(s) | Colorectal Neoplasms/complications ; Colorectal Neoplasms/therapy ; Factor XI Deficiency/complications ; Factor XI Deficiency/therapy ; Hemorrhage/complications ; Hemostasis ; Hemostatics/therapeutic use ; Humans ; Liver Neoplasms/complications ; Liver Neoplasms/secondary ; Liver Neoplasms/therapy ; Male ; Middle Aged ; Neoplasm Metastasis ; Partial Thromboplastin Time ; Plasma ; Plasma Exchange/methods ; Plasmapheresis ; Prothrombin Time ; Reproducibility of Results ; Thrombelastography ; Viscosity |
Chemical Substances | Hemostatics |
Language | English |
Publishing date | 2021-05-31 |
Publishing country | England |
Document type | Case Reports ; Journal Article |
ZDB-ID | 2046795-3 |
ISSN | 1878-1683 ; 1473-0502 |
ISSN (online) | 1878-1683 |
ISSN | 1473-0502 |
DOI | 10.1016/j.transci.2021.103176 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1739: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.